Revision Process for Global/National Pharmacopoeias (PDF)

December 15, 2019
J. Mark Wiggins

J. Mark Wiggins is owner and compendial consultant with Global Pharmacopoeia Solutions LLC.

,
Joseph A. Albanese

Joseph A. Albanese is the director of Analytical Strategy and Compliance at Janssen Research and Development, LLC.

This article describes the revision process and the resulting publication of proposed and official updates for pharmacopoeias around the world.